The Food and Drug Administration (FDA)  faced challenges in monitoring infant formula production and addressing safety complaints, particularly highlighted during the 2021-22 cronobacter infections outbreak. Issues included delays in responding to complaints, internal failures, and a supply crisis due to recalls and plant shutdowns.

In response to congressional demands, the FDA intensified inspections of infant formula production, conducting 47 routine annual inspections in federal fiscal year 2023. Operational improvements involve the issuance of safety information to the industry, hiring investigators for dedicated inspections, and supporting the elevation of Cronobacter to a nationally notifiable disease.

The FDA’s proactive steps, such as hiring staff, establishing the Office of Critical Foods, and seeking additional congressional authority, aim to address shortcomings in monitoring and responding to infant formula safety concerns. These measures aim to enhance oversight, improve communication, and ensure timely responses to complaints, reinforcing the agency’s commitment to infant formula safety.

Source: Food Safety News

Reach out to Fresh Group Food Safety Consulting for any inquiries related to food quality and safety.